NCT03220646 2025-07-09Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain TumorsMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting64 enrolled
NCT03969706 2024-11-18Abemaciclib in Patients with OligodendrogliomaAbramson Cancer Center at Penn MedicinePhase 2 Active not recruiting10 enrolled